VetMedEpilepsy in dogs: potassium bromide (alone or added to phenobarbital) vs phenobarbital alone — POSSIBLE
In dogs with epilepsy, how does potassium bromide — used alone or added to phenobarbital — compare with phenobarbital alone for reducing seizure frequency?
Shelf #289 · gate-verified and approved by the developer
POSSIBLE: The evidence splits by how bromide is used. As a first-choice single drug, the one double-blinded randomised trial (Boothe 2012; 46 AED-naive dogs) found phenobarbital clearly better: seizures were eradicated in 17/20 (85%) on phenobarbital vs 12/23 (52%) on bromide, with a greater percentage decrease in seizure duration on phenobarbital (88 ± 34% vs 49 ± 75%), and seizure activity worsened in 3 bromide-treated dogs only. As an add-on in dogs already failing phenobarbital, the evidence is uncontrolled but consistently favourable: Podell & Fenner 1993 found adding bromide reduced the total number of seizures in 83% of 23 refractory dogs, with seizure-free status in 26%, and Trepanier 1998 found 72% of 122 dogs achieved a 50% or greater reduction in seizure frequency after bromide was started (alone or with a barbiturate), with barbiturate discontinuation possible in 19%. Those add-on figures are before-after comparisons in refractory dogs with no control group, so regression to the mean and concurrent dose changes cannot be excluded. Bottom line: phenobarbital alone beats bromide alone head-to-head; adding bromide helps a majority of phenobarbital-refractory dogs in retrospective series, at moderate certainty. Drafted Nov 10, 2026 (VetMed build, topic #289); all figures from abstracts fetched and verified at drafting.
Boothe 2012: as first-choice monotherapy, phenobarbital eradicated seizures in 85% of dogs vs 52% on bromide
Double-blinded, randomized, parallel, clinical trial (record's own wording; publication type Comparative Study)
Who: Dogs: 46 antiepileptic-drug-naive dogs with naturally occurring epilepsy, in a clinical trial setting, randomised to phenobarbital treatment (21 dogs) or bromide treatment (25 dogs); for either treatment a 7-day loading dose period was initiated along with a maintenance dose adjusted on the basis of monthly monitoring, with efficacy and safety compared between baseline and study end (generally 6 months).
Result: Phenobarbital treatment resulted in eradication of seizures (17/20 [85%]) significantly more often than did bromide (12/23 [52%]); phenobarbital treatment also resulted in a greater percentage decrease in seizure duration (88 ± 34%), compared with bromide (49 ± 75%). Seizure activity worsened in 3 bromide-treated dogs only. In dogs with seizure eradication, mean ± SD serum phenobarbital concentration was 25 ± 6 μg/mL (phenobarbital dosage, 4.1 ± 1.1 mg/kg, p.o., q 12 h) and mean serum bromide concentration was 1.8 ± 0.6 mg/mL (bromide dosage, 31 ± 11 mg/kg, p.o., q 12 h). Ataxia, lethargy, and polydipsia were greater at 1 month for phenobarbital-treated dogs; vomiting was greater for bromide-treated dogs at 1 month and study end. The authors concluded both drugs were reasonable first-choice AEDs, but phenobarbital was more effective and better tolerated during the first 6 months.
Watch out: This is a monotherapy first-choice trial — it compares bromide alone against phenobarbital alone, not bromide added to phenobarbital, so it must not be used to judge add-on therapy. Denominators at study end (20 and 23) are smaller than the numbers randomised (21 and 25). Follow-up was generally 6 months only.
Boothe DM, Dewey C, Carpenter DM. Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs. Journal of the American Veterinary Medical Association. 2012;240(9):1073-83. PMID: 22515627. Registry ID: none in the record. MeSH: Animals · Anticonvulsants/therapeutic use · Bromides/therapeutic use · Dog Diseases/drug therapy · Dogs · Epilepsy/drug therapy · Epilepsy/veterinary · Female · Male · Phenobarbital/therapeutic use · Time Factors · Treatment Outcome
Podell & Fenner 1993: adding bromide to phenobarbital reduced total seizures in 83% of 23 refractory dogs; 26% became seizure-free
Retrospective study (record's own wording: 'On a retrospective basis')
Who: Dogs: 23 refractory canine idiopathic epileptics (1986-1991), all maintained on phenobarbital for at least 4 months before bromide was added, with a mean trough serum phenobarbital concentration of 37.8 mcg/mL and no improvement in seizure severity or recurrence; evaluated before bromide for a mean of 22 months and after bromide for a mean of 15 months (17 dogs followed 12 or more months).
Result: Overall, response to bromide therapy was associated with a reduction in the total number of seizures in 83% of the dogs when compared with their respective pre-bromide period. For those followed for 1 year after bromide, there was a 53% reduction in the number of seizures compared with the previous 12 months. Owners reported a decrease in seizure intensity (65% of dogs) and change to a less severe seizure type (22% of dogs) in dogs that continued to have seizures. Seizure-free status was obtained in 26% of the dogs. Adverse effects of concomitant bromide and phenobarbital therapy were polydipsia (56% of dogs), polyphagia (30%), excessive sedation (30%), and generalized ataxia (17%); the phenobarbital dosage was reduced in 8 dogs (35%) as a result of bromide treatment.
Watch out: No control group and no randomisation: the comparison is each dog's post-bromide period against its own pre-bromide period in dogs selected precisely because they were doing badly, so part of the improvement may be regression to the mean or other management changes. The 83% figure is any reduction in total seizure number, a weaker bar than the 50%-reduction responder definition used by Trepanier.
Podell M, Fenner WR. Bromide therapy in refractory canine idiopathic epilepsy. Journal of Veterinary Internal Medicine. 1993;7(5):318-27. PMID: 8263851. Registry ID: none in the record. MeSH: Animals · Anticonvulsants/therapeutic use · Bromides/administration & dosage · Bromides/adverse effects · Bromides/therapeutic use · Dog Diseases/drug therapy · Dogs · Drug Therapy, Combination · Electroencephalography/veterinary · Epilepsy/drug therapy · Epilepsy/veterinary · Female · Male · Phenobarbital/administration & dosage · Phenobarbital/adverse effects · Phenobarbital/therapeutic use · Prognosis · Retrospective Studies
Trepanier 1998: 72% of 122 epileptic dogs had a 50% or greater seizure-frequency reduction after starting potassium bromide
Retrospective study (record's own design wording)
Who: Dogs: 122 dogs with major motor epilepsy treated with potassium bromide with or without phenobarbital sodium or primidone at Cornell University (May 1992 to May 1996), identified retrospectively through serum submitted for bromide analysis; therapeutic response was defined as a 50% or greater reduction in seizure frequency following initiation of bromide treatment.
Result: 72% of epileptic dogs had a > or = 50% reduction in seizure frequency following initiation of treatment with potassium bromide. Discontinuation of barbiturate treatment was possible in 19% of those dogs originally treated with phenobarbital or primidone. Of those dogs continued on bromide and phenobarbital, 45% maintained seizure control with serum phenobarbital concentrations < 20 micrograms/ml. Significantly higher serum bromide concentrations were required when dogs were initially or eventually treated with bromide alone (mean bromide concentration, 1,906 micrograms/ml) compared with dogs treated with potassium bromide along with a barbiturate (mean bromide concentration, 1,621 micrograms/ml). Suggested therapeutic ranges: serum bromide 810 to 2,400 micrograms/ml with phenobarbital, and 880 to 3,000 micrograms/ml for bromide alone.
Watch out: Retrospective and mixed: bromide alone and bromide-plus-barbiturate dogs are pooled for the 72% responder figure, and dogs were included because serum was submitted for bromide monitoring, which can select for dogs kept on treatment. There is no phenobarbital-alone control arm, so this record cannot by itself show the combination beats phenobarbital alone — it shows what happened after bromide was added, mostly in dogs already on a barbiturate.
Trepanier LA, Van Schoick A, Schwark WS, Carrillo J. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996). Journal of the American Veterinary Medical Association. 1998;213(10):1449-53. PMID: 9828942. Registry ID: none in the record. MeSH: Animals · Anticonvulsants/blood · Anticonvulsants/therapeutic use · Bromides/blood · Bromides/therapeutic use · Dog Diseases/blood · Dog Diseases/drug therapy · Dogs · Drug Therapy, Combination · Epilepsy/blood · Epilepsy/drug therapy · Epilepsy/veterinary · Follow-Up Studies · Phenobarbital/blood · Phenobarbital/therapeutic use · Potassium Compounds/blood · Potassium Compounds/therapeutic use · Primidone/therapeutic use · Retrospective Studies · Treatment Outcome
Synthesis: phenobarbital wins as monotherapy in the only blinded trial; bromide as an add-on helps most refractory dogs in uncontrolled series
Synthesis
Who: Synthesis of the cards above: Boothe 2012 (46 AED-naive dogs, double-blinded randomised parallel trial, phenobarbital vs bromide monotherapy, about 6 months), Podell & Fenner 1993 (23 phenobarbital-refractory dogs, retrospective, bromide added to phenobarbital) and Trepanier 1998 (122 epileptic dogs, retrospective, bromide alone or with phenobarbital/primidone).
Result: (1) Monotherapy head-to-head: phenobarbital eradicated seizures in 85% (17/20) vs bromide 52% (12/23), and bromide was the only arm in which seizure activity worsened (3 dogs) — Boothe. (2) Add-on: after bromide was added in refractory dogs, total seizures fell in 83% (Podell & Fenner; 26% seizure-free) and 72% reached at least a 50% frequency reduction (Trepanier), with barbiturate discontinuation possible in 19% (Trepanier) and phenobarbital dose reduced in 35% (Podell & Fenner). (3) The add-on benefit is real-world consistent but uncontrolled; the monotherapy inferiority of bromide is the only randomised, blinded finding in the pack.
Watch out: Do not merge the two questions: 'bromide instead of phenobarbital' (answer: worse, on blinded randomised evidence) and 'bromide added to phenobarbital' (answer: usually helps, on retrospective before-after evidence) have different answers and different certainty. No carded randomised trial tests the add-on strategy against continued phenobarbital alone.
Synthesis of Boothe DM et al. PMID: 22515627; Podell M et al. PMID: 8263851; Trepanier LA et al. PMID: 9828942. Registry IDs as on the individual cards.
Back to the library index · VetMed home
VetMed is an educational resource, not veterinary advice.